{"id":752234,"date":"2023-04-27T16:05:46","date_gmt":"2023-04-27T20:05:46","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\/"},"modified":"2023-04-27T16:05:46","modified_gmt":"2023-04-27T20:05:46","slug":"chinook-therapeutics-to-present-at-upcoming-investor-conferences-14","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\/","title":{"rendered":"Chinook Therapeutics to Present at Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SEATTLE , April  27, 2023  (GLOBE NEWSWIRE) &#8212; Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Chinook management is scheduled to participate in the following upcoming investor conferences:<\/p>\n<ul>\n<li>\n          <strong>H.C. Wainwright BioConnect Investor Conference <\/strong>\u2013 Fireside chat on Tuesday, May 2<sup>nd<\/sup> at 9:30 am EDT<\/p>\n<\/li>\n<li>\n          <strong>Bank of America Securities Healthcare Conference 2023<\/strong> \u2013 Fireside chat on Wednesday, May 10<sup>th<\/sup> at 2:20 pm EDT<\/li>\n<\/ul>\n<p align=\"left\">To access the audio webcasts and subsequent archived recording of these and other company presentations, please visit the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lzOoAaAslCM9NxJdI27DA7kUKNqwMLhoviBDeQQCPbzbVhDn0nIvwh94KxtLl0BYDTEASsPi9z9LOirmeptmvqywD_oEnn4R7QHJ3KVGYiRJ7RXbJU37Tyig7Ale1hER2a-NCL0cEpV5JuO-j6XvXg==\" rel=\"nofollow noopener\" target=\"_blank\">Investors<\/a>\u00a0section of Chinook\u2019s website. The archived audio webcasts will remain available for replay on Chinook\u2019s website for 90 days.<\/p>\n<p align=\"left\">\n        <strong>About Chinook Therapeutics, Inc.<\/strong><br \/>\n        <br \/>Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing precision medicines for kidney diseases. Chinook\u2019s product candidates are being investigated in rare, severe chronic kidney disorders with opportunities for well-defined clinical pathways. Chinook\u2019s lead program is atrasentan, a phase 3 endothelin receptor antagonist for the treatment of IgA nephropathy and proteinuric glomerular diseases. BION-1301, an anti-APRIL monoclonal antibody, is being evaluated in a phase 1\/2 trial for IgA nephropathy. CHK-336, an oral small molecule LDHA inhibitor for the treatment of hyperoxalurias, is in phase 1 development. In addition, Chinook\u2019s research and discovery efforts are focused on building a pipeline of precision medicines for rare, severe chronic kidney diseases with defined genetic and molecular drivers. Chinook is leveraging insights from kidney single cell RNA sequencing and large CKD patient cohorts that have been comprehensively panomically phenotyped, with retained biosamples and prospective clinical follow-up, to discover and develop therapeutic candidates with mechanisms of action targeted against key kidney disease pathways. To learn more, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=z8C9IvmhCEhKwbr0Mo6YQp9JEb1foJHnUbdoOeBJd48qxR8kdXWoA1kZkUR3x7P7HQ2C8q4W0QxbKguVaokaVw==\" rel=\"nofollow noopener\" target=\"_blank\">www.chinooktx.com<\/a>.<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNzQ0OSM1NTYyNTQ3IzIwMTExODc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OTYxNzdiMGMtY2Y0NS00MmNiLThjOTAtY2Y4MzdkMzRmYWU0LTEwMjI3NjA=\/tiny\/Chinook-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Contact:\r\nNoopur Liffick\r\nSenior Vice President, Investor Relations &amp; Corporate Communications\r\ninvestors@chinooktx.com\r\nmedia@chinooktx.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SEATTLE , April 27, 2023 (GLOBE NEWSWIRE) &#8212; Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Chinook management is scheduled to participate in the following upcoming investor conferences: H.C. Wainwright BioConnect Investor Conference \u2013 Fireside chat on Tuesday, May 2nd at 9:30 am EDT Bank of America Securities Healthcare Conference 2023 \u2013 Fireside chat on Wednesday, May 10th at 2:20 pm EDT To access the audio webcasts and subsequent archived recording of these and other company presentations, please visit the\u00a0Investors\u00a0section of Chinook\u2019s website. The archived audio webcasts will remain available for replay on Chinook\u2019s website for 90 days. About Chinook Therapeutics, Inc. Chinook Therapeutics, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Chinook Therapeutics to Present at Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-752234","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Chinook Therapeutics to Present at Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chinook Therapeutics to Present at Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SEATTLE , April 27, 2023 (GLOBE NEWSWIRE) &#8212; Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Chinook management is scheduled to participate in the following upcoming investor conferences: H.C. Wainwright BioConnect Investor Conference \u2013 Fireside chat on Tuesday, May 2nd at 9:30 am EDT Bank of America Securities Healthcare Conference 2023 \u2013 Fireside chat on Wednesday, May 10th at 2:20 pm EDT To access the audio webcasts and subsequent archived recording of these and other company presentations, please visit the\u00a0Investors\u00a0section of Chinook\u2019s website. The archived audio webcasts will remain available for replay on Chinook\u2019s website for 90 days. About Chinook Therapeutics, Inc. Chinook Therapeutics, &hellip; Continue reading &quot;Chinook Therapeutics to Present at Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-27T20:05:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNzQ0OSM1NTYyNTQ3IzIwMTExODc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Chinook Therapeutics to Present at Upcoming Investor Conferences\",\"datePublished\":\"2023-04-27T20:05:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\\\/\"},\"wordCount\":287,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNzQ0OSM1NTYyNTQ3IzIwMTExODc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\\\/\",\"name\":\"Chinook Therapeutics to Present at Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNzQ0OSM1NTYyNTQ3IzIwMTExODc=\",\"datePublished\":\"2023-04-27T20:05:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNzQ0OSM1NTYyNTQ3IzIwMTExODc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNzQ0OSM1NTYyNTQ3IzIwMTExODc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Chinook Therapeutics to Present at Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Chinook Therapeutics to Present at Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\/","og_locale":"en_US","og_type":"article","og_title":"Chinook Therapeutics to Present at Upcoming Investor Conferences - Market Newsdesk","og_description":"SEATTLE , April 27, 2023 (GLOBE NEWSWIRE) &#8212; Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Chinook management is scheduled to participate in the following upcoming investor conferences: H.C. Wainwright BioConnect Investor Conference \u2013 Fireside chat on Tuesday, May 2nd at 9:30 am EDT Bank of America Securities Healthcare Conference 2023 \u2013 Fireside chat on Wednesday, May 10th at 2:20 pm EDT To access the audio webcasts and subsequent archived recording of these and other company presentations, please visit the\u00a0Investors\u00a0section of Chinook\u2019s website. The archived audio webcasts will remain available for replay on Chinook\u2019s website for 90 days. About Chinook Therapeutics, Inc. Chinook Therapeutics, &hellip; Continue reading \"Chinook Therapeutics to Present at Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-27T20:05:46+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNzQ0OSM1NTYyNTQ3IzIwMTExODc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Chinook Therapeutics to Present at Upcoming Investor Conferences","datePublished":"2023-04-27T20:05:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\/"},"wordCount":287,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNzQ0OSM1NTYyNTQ3IzIwMTExODc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\/","name":"Chinook Therapeutics to Present at Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNzQ0OSM1NTYyNTQ3IzIwMTExODc=","datePublished":"2023-04-27T20:05:46+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNzQ0OSM1NTYyNTQ3IzIwMTExODc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNzQ0OSM1NTYyNTQ3IzIwMTExODc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chinook-therapeutics-to-present-at-upcoming-investor-conferences-14\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Chinook Therapeutics to Present at Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/752234","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=752234"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/752234\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=752234"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=752234"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=752234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}